Endothelin receptor subtype antagonist activity of S-0139 in various isolated rabbit and canine arteries

European Journal of Pharmacology

Volumn 400, Issue 2-3, 2000, Pages 255-262

  Iwasaki, Takanori ^a   Hayasaki Kajiwara, Yoko ^a   Shimamura, Toshitake ^a   Naya, Noriyuki ^a   Nakajima, Masatoshi ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

Antagonist activity; Blood vessel, canine; Blood vessel, rabbit; Endothelin receptor subtype; S 0139

Indexed keywords

27 O 3 [2 (3 CARBOXYACRYLOYLAMINO) 5 HYDROXYPHENYL]ACRYLOYLOXY MYRICERONE; 27 O 3 [2 (3 CARBOXYACRYLOYLAMINO) 5 HYDROXYPHENYL]ACRYLOYLOXYMYRICENONE; BOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN 1 [11-21]; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; RECEPTOR SUBTYPE; SARAFOTOXIN S6C; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERY; ARTICLE; BASILAR ARTERY; CONTROLLED STUDY; CORONARY ARTERY; DOG; DOSE RESPONSE; ENDOTHELIUM; FEMORAL ARTERY; IN VITRO STUDY; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; RABBIT; RENAL ARTERY; SMOOTH MUSCLE CONTRACTILITY;

ANIMALS; ARTERIES; CAFFEIC ACIDS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENDOTHELIN-1; ENDOTHELIN-3; ENDOTHELIUM, VASCULAR; ISOMETRIC CONTRACTION; MALE; MUSCLE, SMOOTH, VASCULAR; OLEANOLIC ACID; RABBITS; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; VASOCONSTRICTOR AGENTS; VIPER VENOMS;

EID: 0034698356     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00417-9     Document Type: Article

References (32)

1. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 348:1990;730-732.
2. Arunlakshana O., Schild H.O. Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14:1959;48-58.
3. Bax W.A., Saxena P.R. The current endothelin receptor classification: time for reconsideration? Trends Pharmacol. Sci. 15:1994;379-386.
4. Bax W.A., Aghai Z., van Tricht C.L.J., Wassenaar C., Saxena P.R. Different endothelin receptors involved in endothelin-1- and sarafotoxin S6B-induced contractions of the human isolated coronary artery. Br. J. Pharmacol. 113:1994;1471-1479.
5. Burns L., Clark K.L., Bradley J., Robertson M.J., Clark A.J.L. Molecular cloning of the canine angiotensin II receptor. FEBS Lett. 343:1994;146-150.
6. De Nucci G., Thomas R., D'Orléans-Juste P., Antunes E., Walder C., Warner T.D., Vane J.R. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. U. S. A. 85:1988;9797-9800.
7. Doherty A.M., Cody W.L., DePue P.L., He J.X., Waite L.A., Leonard D.M., Leitz N.L., Dudley D.T., Rapundalo S.T., Hingorani G.P., Haleen S.J., LaDouceur D.M., Hill K.E., Flynn M.A., Reynolds E.E. Structure-activity relationships of C-terminal endothelin hexapeptide antagonists. J. Med. Chem. 36:1993;2585-2594.
8. Douglas S.A., Meek T.D., Ohlstein E.H. Novel receptor antagonists welcome a new era in endothelin biology. Trends Pharmacol. Sci. 15:1994;313-316.
9. 50 for a logistic response curve. Sankhyã 12:1953;121-136.
10. Gellai M., Fletcher T., Pullen M., Nambi P. Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat. Am. J. Physiol. 271:1996;R254-R261.
11. B) receptors in rabbit isolated pulmonary artery and bronchus. Br. J. Pharmacol. 118:1996;1209-1217.
12. Hirose H., Ide K., Sasaki T., Takahashi R., Kobayashi M., Ikemoto F., Yano M., Nishikibe M. The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog. Eur. J. Pharmacol. 277:1995;77-87.
13. Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. U. S. A. 86:1989;2863-2867.
14. B receptor in rabbit mesenteric arteries. Am. J. Physiol. 276:1999;H383-H390.
15. B2 receptors, BQ-788: effects on blood vessel and small intestine. Biochem. Biophys. Res. Commun. 205:1994;168-173.
16. Kita T., Kubo K., Hiramatsu K., Sakaki T., Yonetani Y., Sato S., Fujimoto M., Nakashima T. Profiles of an intravenously available endothelin A-receptor antagonist, S-0139, for preventing cerebral vasospasm in a canine two-hemorrhage model. Life Sci. 63:1998;305-315.
17. A receptor subtype. Eur. J. Pharmacol. 342:1998;319-324.
18. B-receptors in the human saphenous vein. Jpn. J. Pharmacol. 69:1995;391-398.
19. A receptor-mediated contractions in the rabbit saphenous vein. Eur. J. Pharmacol. 286:1995;209-212.
20. Ohlstein E.H., Beck G.R. Jr., Douglas S.A., Nambi P., Lago M.A., Gleason J.G., Ruffolo R.R. Jr., Feuerstein G., Elliott J.D. Nonpeptide endothelin receptor antagonists: II. Pharmacological characterization of SB209670. J. Pharmacol. Exp. Ther. 271:1994;762-768.
21. Rhaleb N.E., Rouissi N., Nantel F., D'Orléans-Juste P., Regoli D. Dup753 is a specific antagonist for the angiotensin receptor. Hypertension. 17:1991;480-484.
22. Rigel D.F., Lappe R.W. Differential responsiveness of conduit and resistance coronary arteries to endothelin A and B receptor stimulation in anesthetized dogs. J. Cardiovasc. Pharmacol. 22(Suppl. 8):1993;S243-S247.
23. Robertson M.J., Dougall I.G., Harper D., McKechnie K.C.W., Leff P. Agonist-antagonist interactions at angiotensin receptors: application of a two-state receptor model. Trends Pharmacol. Sci. 15:1994;364-369.
24. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 348:1990;732-735.
25. A-receptor antagonist, S-0139, on cerebral vasospasm and behavioral changes in dogs intracisternally administered endothelin-1. Life Sci. 62:1998;PL191-PL197.
26. B receptors mediating venous smooth muscle contraction. Biochem. Biophys. Res. Commun. 200:1994;627-633.
27. Suzuki R., Masaoka H., Hirata Y., Marumo F., Isotani E., Hirakawa K. The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J. Neurosurg. 77:1992;96-100.
28. Tanoi C., Suzuki Y., Shibuya M., Sugita K., Masuzawa-Ito K., Asano M. Comparison of vasoconstrictor actions of endothelin-1 in cerebral, coronary, and mesenteric arteries of the dog. J. Cardiovasc. Pharmacol. 19:1992;568-579.
29. B receptors in canine coronary arteries. Circ. Res. 74:1994;105-114.
30. B contractile receptors. Eur. J. Pharmacol. 257:1994;307-310.
31. Williams D.L. Jr., Murphy K.L., Nolan N.A., O'Brien J.A., Pettibone D.J., Kivlighn S.D., Krause S.M., Lis E.V. Jr., Zingaro G.J., Gabel R.A., Clayton F.C., Siegl P.K.S., Zhang K., Naue J., Vyas K., Walsh T.F., Fitch K.J., Chakravarty P.K., Greenlee W.J., Clineschmidt B.V. Pharmacology of L-754,142, a highly potent, orally active nonpeptidyl endothelin antagonist. J. Pharmacol. Exp. Ther. 275:1995;1518-1526.
32. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.